Neil Chatterji
Stock Analyst at B. Riley Securities
(0.38)
# 2542
Out of 5,343 analysts
24
Total ratings
38.46%
Success rate
3.73%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CLPT ClearPoint Neuro | Maintains: Strong Buy | 15 20 | 12.22 | 63.67% | 2 | Jan 28, 2025 | |
OPRX OptimizeRx | Maintains: Buy | 17 13 | 11.93 | 8.97% | 3 | Dec 24, 2024 | |
AUGX Augmedix | Reinstates: Buy | 6 | n/a | n/a | 3 | Apr 3, 2024 | |
ESTA Establishment Labs H... | Maintains: Buy | 95 50 | 36.97 | 35.24% | 2 | Nov 9, 2023 | |
SILK Silk Road Medical | Downgrades: Neutral | 54 14 | n/a | n/a | 3 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 | 1.59 | 371.7% | 1 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 18 | 12.37 | 45.51% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | 2.81 | 60.14% | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 4 | 0.58 | 503.45% | 3 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 2.04 | 169.61% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | n/a | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 2.19 | 333.79% | 1 | Oct 4, 2022 |